https://doi.org/10.4081/monaldi.2025.3281
Bronchoscopic valve therapy for tuberculosis: a scoping review
Submitted: November 29, 2024
Accepted: January 8, 2025
Published: March 5, 2025
Accepted: January 8, 2025
Abstract Views: 328
PDF_EARLY VIEW: 100
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Authors
The management of tuberculosis (TB) presents significant challenges, particularly in the context of multidrug-resistant TB (MDR-TB) and TB-HIV co-infection. Traditional surgical interventions, such as lung resection and pneumothorax induction, have largely been phased out with the advent of modern antibiotic regimens. However, emerging evidence suggests that endobronchial interventions, specifically the use of unidirectional valves, have potential in supporting the treatment of MDR-TB. The objective of this review is to demonstrate the feasibility of closure of tubercular cavities using endobronchial valves, resulting in improved clinical outcomes and sputum smear conversion. PubMed was searched from inception to September 2024. The small studies reviewed here demonstrate the feasibility of tubercular cavity closure using endobronchial valves, resulting in improved clinical outcomes and sputum smear conversion. Yet, limited access to Food and Drug Administration-approved valves and funding challenges hinders large-scale trials. To address these limitations, further evidence is needed within improved international collaboration. We suggest that international prospective trials and innovation are needed. Such collaborative efforts would clarify the role of valves in TB treatment and hopefully lead to the development of simpler and more affordable occlusive devices that would benefit patients with MDR-TB, particularly in low-income countries.
World Health Organization. Global tuberculosis report: 2022. Available from: https://www.who.int/teams/global-tuberculosis-programme/tb-reports/global-tuberculosis-report-2022.
Marrone MT, Venkataramanan V, Goodman M, et al. Surgical interventions for drug-resistant tuberculosis: a systematic review and meta-analysis. Int J Tuberc Lung Dis 2013;17:6-16.
DOI: https://doi.org/10.5588/ijtld.12.0198
Calligaro GL, Moodley L, Symons G, Dheda K. The medical and surgical treatment of drug-resistant tuberculosis. J Thorac Dis 2014;6:186-95.
Drain PK, Bajema KL, Dowdy D, et al. Incipient and subclinical tuberculosis: a clinical review of early stages and progression of infection. Clin Microbiol Rev 2018;31:e00021-18.
DOI: https://doi.org/10.1128/CMR.00021-18
Paton NI, Cousins C, Suresh C, et al. Treatment strategy for rifampin-susceptible tuberculosis. N Engl J Med 2023;388:873-87.
DOI: https://doi.org/10.1056/NEJMoa2212537
WHO. WHO consolidated guidelines on tuberculosis: module 4: treatment - drug-susceptible tuberculosis treatment. 2022. Available from: https://www.who.int/publications/i/item/9789240048126.
Edessa D, Sisay M, Dessie Y. Unfavorable outcomes to second-line tuberculosis therapy among HIV-infected versus HIV-uninfected patients in sub-Saharan Africa: a systematic review and meta-analysis. PLoS One 2020;15:e0237534.
DOI: https://doi.org/10.1371/journal.pone.0237534
Kempker RR, Vashakidze S, Solomonia N, et al. Surgical treatment of drug-resistant tuberculosis. Lancet Infect Dis 2012;12:157-66.
DOI: https://doi.org/10.1016/S1473-3099(11)70244-4
Toma TP, Hopkinson NS, Hillier J, et al. Bronchoscopic volume reduction with valve implants in patients with severe emphysema. Lancet 2003;361:931-3.
DOI: https://doi.org/10.1016/S0140-6736(03)12762-6
Criner GJ, Wright S, Sue R, et al. Effectiveness of the zephyr® endobronchial valves (EBV®) in patients with severe emphysema: clinical outcomes from liberate, a multicenter RCT. Am J Respir Crit Care Med 2018;198:1151-64.
DOI: https://doi.org/10.1164/rccm.201803-0590OC
Corbetta L, Tofani A, Montinaro F, et al. Lobar collapse therapy using endobronchial valves as a new complementary approach to treat cavities in multidrug-resistant tuberculosis and difficult-to-treat tuberculosis: a case series. Respiration 2016;92:316-28.
DOI: https://doi.org/10.1159/000450757
Levin A, Sklyuev S, Felker I, et al. Endobronchial valve treatment of destructive multidrugresistant tuberculosis. Int J Tuberc Lung Dis 2016;20:1539-45.
DOI: https://doi.org/10.5588/ijtld.16.0033
An H, Liu X, Wang T, et al. Endobronchial valve treatment of tuberculous cavities in patients with multidrug-resistant pulmonary tuberculosis: a randomized clinical study. Pathogens 2022;11:899.
DOI: https://doi.org/10.3390/pathogens11080899
Popova LA, Shergina EA, Lovacheva OV, et al. Change in lung function early after endoscopic bronchial valve placement in patients with chronic cavitary tuberculosis. Pulmonologiya 2018;28:332-40.
DOI: https://doi.org/10.18093/0869-0189-2018-28-3-332-340
Popova LA, Shergina EA, Bagdasaryan TP, et al. The change of ventilation and gas exchange function of the lungs as the result of endoscopic valvular bronchial blocking in patients with recurrent fibro-cavernous tuberculosis after lung resection. Medical Alphabet 2019;3:8-15.
DOI: https://doi.org/10.33667/2078-5631-2019-3-29(404)-8-15
Togo T, Atsumi J, Hiramatsu M, et al. A novel approach to extensive clarithromycin-resistant mycobacterium avium complex pulmonary disease. Ann Thorac Cardiovasc Surg 2022;28:444-7.
DOI: https://doi.org/10.5761/atcs.cr.21-00010
Song X, Gu Y, Wang H, Zhang L. The efficacy of endobronchial valves for the treatment of bronchopleural fistula: a single-arm clinical trial. J Thorac Dis 2022;14:712-20.
DOI: https://doi.org/10.21037/jtd-22-258
Lalla U, Allwood BW, Sinha Roy S, et al. Endobronchial valve used as salvage therapy in a mechanically ventilated patient with intractable life-threatening haemoptysis. Respiration 2017;93:436-40.
DOI: https://doi.org/10.1159/000465526
Diab K, Rieger K, Noor A. Endobronchial valve placement for pulmonary tuberculosis-related bronchocutaneous fistula after thoracoplasty. J Bronchology Interv Pulmonol 2020;27:294-6.
DOI: https://doi.org/10.1097/LBR.0000000000000688
Gompelmann D, Dheda K. Endoscopic valve therapy: a new therapeutic approach for otherwise incurable tuberculosis? Respiration 2017;93:79-80.
DOI: https://doi.org/10.1159/000453621
How to Cite
Agarwal, Kshitij, Adam T. Gray, Tudor P. Toma, Valentina Luzzi, and Lorenzo Corbetta. 2025. “Bronchoscopic Valve Therapy for Tuberculosis: A Scoping Review”. Monaldi Archives for Chest Disease, March. https://doi.org/10.4081/monaldi.2025.3281.
Copyright (c) 2025 The Author(s)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.
Similar Articles
- Mariana Buziashvili, Hayk Davtyan, Yuliia Sereda, Olga Denisiuk, Ogtay Gozalov, Nino Lomtadze, Arax Hovhannesyan, Incidence rate and time to serious adverse events among rifampicin resistant tuberculosis patients in Georgia treated with new and repurposed anti-tuberculosis drugs, 2016-2018 , Monaldi Archives for Chest Disease: Vol. 91 No. 1 (2021)
- C. Incorvaia, C. Pravettoni, M. Mauro, M.-R. Yacoub, F. Tarantini, G.G. Riario-Sforza, Effectiveness of omalizumab in a patient with severe asthma and atopic dermatitis , Monaldi Archives for Chest Disease: Vol. 69 No. 2 (2008): Pulmonary series
- Natalia Adamashvili, Kristina Akopyan, Nestani Tukvadze, Kostyantyn Dumchev, Yuliia Sereda, Irma Khonelidze, Giorgi Kuchukhidze, Factors associated with loss to follow-up among people with tuberculosis in the country of Georgia: a cohort study , Monaldi Archives for Chest Disease: Vol. 91 No. 1 (2021)
- Luca Degli Esposti, Diego Sangiorgi, Marcello Arca, Giovanni B. Vigna, Stefano Buda, Ezio Degli Esposti, Achievement of therapeutic target in subjects on statin treatment in clinical practice. Results of the STAR (Statins Target Assessment in Real practice) study , Monaldi Archives for Chest Disease: Vol. 76 No. 4 (2011): Cardiac series
- J.A. Gullón, I. Suárez, M. Lecuona, R. Fernández, G. Rubinos, A. Medina, C. Cabrera, I. González, Time to culture conversion in smokers with pulmonary tuberculosis , Monaldi Archives for Chest Disease: Vol. 71 No. 3 (2009): Pulmonary series
- I. Blanco, H. Canto, J. Flóres, C. Camblor, V. Cárcaba, F.J. de Serres, S. Janciauskiene, E.F. Bustillo, Long-term augmentation therapy with Alpha-1 Antitrypsin in an MZ-AAT severe persistent asthma , Monaldi Archives for Chest Disease: Vol. 69 No. 4 (2008): Pulmonary series
- D. Lykouras, F. Sampsonas, A. Kaparianos, K. Karkoulias, G. Tsoukalas, K. Spiropoulos, Human genes in TB infection: their role in immune response , Monaldi Archives for Chest Disease: Vol. 69 No. 1 (2008): Pulmonary series
- Halil Yanardag, Cuneyt Tetikkurt, Muammer Bilir, Clinical and prognostic significance of muscle biopsy in sarcoidosis , Monaldi Archives for Chest Disease: Vol. 88 No. 1 (2018)
- A. Kaya, Z. Topu, S. Fitoz, N. Numanoglu, Pulmonary tuberculosis with multifocal skeletal involvement , Monaldi Archives for Chest Disease: Vol. 61 No. 2 (2004): Pulmonary series
- Debapriya Maji, Upasna Agarwal, Lokender Kumar, Vinay V, Amit Sharma, Clinicodemographic profile and outcome of tuberculosis treatment in TB-HIV co-infected patients receiving daily ATT under a single window TB-HIV services delivery initiative , Monaldi Archives for Chest Disease: Vol. 93 No. 3 (2023)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
You may also start an advanced similarity search for this article.
